Cargando…

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort

BACKGROUND: Recurrence and metastases are still frequent outcomes after initial tumour control in women diagnosed with breast cancer. Although therapies are selected based on tumour characteristics measured at baseline, prognostic biomarkers can identify those at risk of poor outcomes. Circulating p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prieur, Alexandre, Harper, Andrew, Khan, Momtafin, Vire, Bérengère, Joubert, Dominique, Payen, Léa, Kopciuk, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071601/ https://www.ncbi.nlm.nih.gov/pubmed/37016331 http://dx.doi.org/10.1186/s12885-023-10729-1

Ejemplares similares

Prognostic Value of Plasma hPG(80) (Circulating Progastrin) in Metastatic Renal Cell Carcinoma
por: Kohli, Manish, et al.
Publicado: (2021)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
por: You, Benoit, et al.
Publicado: (2019)

hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
por: Casile, Melanie, et al.
Publicado: (2023)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Dupuy, Marie, et al.
Publicado: (2022)

Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma
por: Doucet, L., et al.
Publicado: (2023)

Inactivation of the lysine binding sites of human plasminogen (hPg) reveals novel structural requirements for the tight hPg conformation, M-protein binding, and rapid activation
por: Ayinuola, Yetunde A., et al.
Publicado: (2023)

Circulating PCSK9 levels and 2-hPG are positively correlated in metabolic diseases in a Chinese Han population
por: Guo, Wen, et al.
Publicado: (2018)

Targeting progastrin enhances radiosensitization of colorectal cancer cells
por: Kowalski-Chauvel, Aline, et al.
Publicado: (2017)

Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring
por: Barchiesi, Vittoria, et al.
Publicado: (2021)

Association between Serum Progastrin Biomarker Level and Gastric Cancer
por: Amjadi, Omolbanin, et al.
Publicado: (2022)

Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients
por: Li, Li, et al.
Publicado: (2020)

A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria
por: Tutuncu, Yildiz, et al.
Publicado: (2016)

Progastrin Represses the Alternative Activation of Human Macrophages and Modulates Their Influence on Colon Cancer Epithelial Cells
por: Hernández, Carlos, et al.
Publicado: (2014)

Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy
por: Li, Ming, et al.
Publicado: (2020)

Instability of Plasma and Serum Progastrin-Releasing Peptide During Repeated Freezing and Thawing
por: Lee, Jae-Eun, et al.
Publicado: (2016)

Acute effects of N‐terminal progastrin fragments on gastric acid secretion in man
por: Goetze, Jens P., et al.
Publicado: (2017)

Insulin-Like Factor 3 and the HPG Axis in the Male
por: Ivell, Richard, et al.
Publicado: (2014)

A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047
por: Kuo, Wen-Lin, et al.
Publicado: (2009)

Diagnostic and therapeutic value of progastrin‐releasing peptide on small‐cell lung cancer: A Single‐Center Experience in China
por: Wu, Xiao‐Yuan, et al.
Publicado: (2018)

The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis
por: Jin, Guangchun, et al.
Publicado: (2017)

Effects of estradiol and FSH on maturation of the testis in the hypogonadal (hpg) mouse
por: Baines, Helen, et al.
Publicado: (2008)

HPG pore: an efficient and scalable framework for nanopore sequencing data
por: Tarraga, Joaquin, et al.
Publicado: (2016)

HPG-DHunter: an ultrafast, friendly tool for DMR detection and visualization
por: Fernández, Lisardo, et al.
Publicado: (2020)

HPG-Dependent Peri-Pubertal Regulation of Adult Neurogenesis in Mice
por: Trova, Sara, et al.
Publicado: (2020)

The Family Biorhythm: Contributions of the HPA and HPG Axes to Neuroendocrine Attunement
por: Wood, Erin E., et al.
Publicado: (2023)

RAP80 expression in breast cancer and its relationship with apoptosis in breast cancer cells
por: Jin, Guanghua, et al.
Publicado: (2019)

Creation of a Métis-Specific Instrument for Cancer Screening: A Scoping Review of Cancer-Screening Programs and Instruments
por: Letendre, Angeline, et al.
Publicado: (2023)

Risk of contralateral breast cancer in Denmark 1943-80.
por: Storm, H. H., et al.
Publicado: (1986)

HABP2 p.G534E variant in patients with family history of thyroid and breast cancer
por: Pinheiro, Maisa, et al.
Publicado: (2017)

Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
por: Tagliaferri, Barbara, et al.
Publicado: (2020)

Study on the Mechanism of Sarsasapogenin in Treating Precocious Puberty by Regulating the HPG Axis
por: Hu, Kaili, et al.
Publicado: (2020)

RFamide peptides, the novel regulators of mammalian HPG axis: A review
por: Mohapatra, Smruti Smita, et al.
Publicado: (2021)

Circadian Rhythms Within the Female HPG Axis: From Physiology to Etiology
por: Shao, Shuyi, et al.
Publicado: (2021)

Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
por: TUTAR, Nuri, et al.
Publicado: (2019)

Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice
Publicado: (1994)

High HPgV replication is associated with improved surrogate markers of HIV progression
por: Horemheb-Rubio, Gibran, et al.
Publicado: (2017)

Atrazine Exposure and Reproductive Dysfunction through the Hypothalamus-Pituitary-Gonadal (HPG) Axis
por: Wirbisky, Sara E., et al.
Publicado: (2015)

Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer
por: Dobrescu, Andrei, et al.
Publicado: (2011)

Protective Role of the PG1036-PG1037-PG1038 Operon in Oxidative Stress in Porphyromonas gingivalis W83
por: Henry, Leroy G., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ip2uktg0138k1okkku931jr51g